![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.
CAMBRIDGE, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of June 1, 2024, the...
On-track for trem-cel and VCAR33ALLO clinical updates in the second half of 2024Trem-cel trial expanded to include patients with myelodysplastic syndromes (MDS); Mylotarg™ dosing has advanced to...
CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.306 | -25.0819672131 | 1.22 | 1.27 | 0.9 | 460633 | 1.1373515 | CS |
4 | -0.516 | -36.0839160839 | 1.43 | 1.45 | 0.9 | 306060 | 1.19961312 | CS |
12 | -1.256 | -57.8801843318 | 2.17 | 2.2 | 0.9 | 279677 | 1.52419711 | CS |
26 | -1.336 | -59.3777777778 | 2.25 | 3.1399 | 0.9 | 292903 | 1.87208746 | CS |
52 | -2.226 | -70.8917197452 | 3.14 | 3.48 | 0.9 | 205667 | 2.01399988 | CS |
156 | -19.286 | -95.4752475248 | 20.2 | 20.9 | 0.9 | 160016 | 5.2183657 | CS |
260 | -41.106 | -97.8248453118 | 42.02 | 63.62 | 0.9 | 166434 | 9.87038165 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions